|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|
| ASSETS | ||||
| Deferred offering costs | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Total current assets | ||||
| Cash and marketable securities held in Trust Account | ||||
| TOTAL ASSETS | ||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||
| Current liabilities – accrued expenses | ||||
| Promissory note – related party | ||||
| Total Current Liabilities | ||||
| Executive Loans | ||||
| Warrant Liability | ||||
| Deferred underwriting fee payable | ||||
| Total Liabilities | ||||
| Class A ordinary shares subject to possible redemption, 80,499,090 and 62,011,512 shares at redemption value at June 30, 2021 and December 31, 2020, respectively. | ||||
| Shareholders’ Equity | ||||
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 0 and 18,487,578 shares issued and outstanding (excluding 80,499,090 and 62,011,512 shares subject to possible redemption) as of June 30, 2021 and December 31, 2020, respectively. | ||||
| Class A ordinary shares | ||||
| Class B ordinary shares | ||||
| Total class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 0 and 18,487,578 shares issued and outstanding (excluding 80,499,090 and 62,011,512 shares subject to possible redemption) as of June 30, 2021 and December 31, 2020, respectively. | ||||
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 8,944,343 shares issued and outstanding at June 30, 2021 and December 31, 2020 | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Class A ordinary shares | ||||
| Class B ordinary shares | ||||
| Total Shareholders’ Equity | ||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
Loading...
